Xu Chunxiao, Zang Yusheng, Zhao Yuxiang, Cui Weiqiang, Zhang Hong, Zhu Yingcui, Xu Man
Department of Cardiology, Sunshine Union Hospital, Weifang, China.
School of Medicine, Kunming University of Science and Technology, Kunming, China.
Front Oncol. 2021 Mar 25;11:652211. doi: 10.3389/fonc.2021.652211. eCollection 2021.
Autophagy related protein 5 (ATG5) is an important autophagosome formation related protein, and its involvement in the biological process of autophagy has been shown to correlate with tumor metabolic patterns and the formation of tumor heterogeneity. However, the role of ATG5 in tumor metabolism and tumor immunity remains unclear.
In order to explore this problem, this study was designed to reveal the role of ATG5 in tumor metabolism and tumor immunity through pan-cancer analysis of multi-database. GTEx database, CCLE database, and TCGA database were used to describe the expression, prognosis, immune microenvironment, immune new antigen, immune checkpoint, TMB, and microsatellite instability of ATG5 in 33 types of tumors. A series of bioinformatics tools and methods were used for quantitative analysis and panoramic description, such as to Estimate, Scanneo and GSEA.
The differential analysis results of multiple databases showed that ATG5 was ubiquitously highly expressed in pan-cancer, especially in solid tumors. Survival analysis revealed that ATG5 was universally associated with the prognosis of pan-cancer, and high ATG5 expression was significantly associated with poor patient prognosis in most cases. Further, the expression level of ATG5 was confirmed to be associated with tumor immune infiltration and tumor microenvironment, especially in BRCA, KIRC, and LIHC. In addition to this, ATG5 expression was confirmed to correlate with these clinically significant phenotypes, in conjunction with immune neoantigens and immune checkpoint gene expression profiles in pan-cancer. In addition to TMB and microsatellite instability in pan-cancer, we confirmed that ATG5 expression affects the expression of DNA repair genes and methyltransferases in pan-cancer, and found through gene set enrichment analysis that ATG5 is involved in the regulation of numerous signaling pathways involved in cancer metabolism and cancer immunity.
ATG5 participated in the formation of autophagosomal membrane important molecule LC3-II outside, and played an important role in tumor metabolism and tumor immunity. The comprehensive pan-cancer analysis not only revealed the potential of ATG5 in tumor-targeted therapy but also suggested ATG5 as a promising tumor predictive biomarker in most solid tumors.
自噬相关蛋白5(ATG5)是一种重要的自噬体形成相关蛋白,其参与自噬的生物学过程已被证明与肿瘤代谢模式及肿瘤异质性的形成相关。然而,ATG5在肿瘤代谢和肿瘤免疫中的作用仍不清楚。
为探究此问题,本研究旨在通过多数据库的泛癌分析揭示ATG5在肿瘤代谢和肿瘤免疫中的作用。使用GTEx数据库、CCLE数据库和TCGA数据库来描述ATG5在33种肿瘤中的表达、预后、免疫微环境、免疫新抗原、免疫检查点、肿瘤突变负荷(TMB)和微卫星不稳定性。采用了一系列生物信息学工具和方法进行定量分析和全景描述,如Estimate、Scanneo和基因集富集分析(GSEA)。
多个数据库的差异分析结果显示,ATG5在泛癌中普遍高表达,尤其是在实体瘤中。生存分析表明,ATG5普遍与泛癌的预后相关,在大多数情况下,ATG5高表达与患者预后不良显著相关。此外,ATG5的表达水平被证实与肿瘤免疫浸润和肿瘤微环境相关,尤其是在乳腺癌(BRCA)、肾透明细胞癌(KIRC)和肝细胞癌(LIHC)中。除此之外,结合泛癌中的免疫新抗原和免疫检查点基因表达谱,证实ATG5表达与这些临床显著表型相关。除了泛癌中的TMB和微卫星不稳定性外,我们还证实ATG5表达影响泛癌中DNA修复基因和甲基转移酶的表达,并通过基因集富集分析发现ATG5参与了众多与癌症代谢和癌症免疫相关的信号通路的调控。
ATG5参与自噬体膜重要分子LC3-II的形成,在肿瘤代谢和肿瘤免疫中发挥重要作用。全面的泛癌分析不仅揭示了ATG5在肿瘤靶向治疗中的潜力,还表明ATG5在大多数实体瘤中是一种有前景的肿瘤预测生物标志物。